Vanessa Buatois

1.4k total citations
34 papers, 874 citations indexed

About

Vanessa Buatois is a scholar working on Immunology, Oncology and Biomaterials. According to data from OpenAlex, Vanessa Buatois has authored 34 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 9 papers in Oncology and 8 papers in Biomaterials. Recurrent topics in Vanessa Buatois's work include Phagocytosis and Immune Regulation (11 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Vanessa Buatois is often cited by papers focused on Phagocytosis and Immune Regulation (11 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (9 papers). Vanessa Buatois collaborates with scholars based in Switzerland, France and United States. Vanessa Buatois's co-authors include Marie Kosco‐Vilbois, Walter Ferlin, François Guilhot, Laurence Chatel, Graziano Pelli, François Mach, Giovanni Magistrelli, Eric Hatterer, Limin Shang and Pauline Malinge and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Vanessa Buatois

33 papers receiving 866 citations

Peers

Countries citing papers authored by Vanessa Buatois

Since Specialization

Citations

This map shows the geographic impact of Vanessa Buatois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Buatois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Buatois more than expected).

Fields of papers citing papers by Vanessa Buatois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Buatois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Buatois. The network helps show where Vanessa Buatois may publish in the future.

Co-authorship network of co-authors of Vanessa Buatois

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Buatois. A scholar is included among the top collaborators of Vanessa Buatois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Buatois. Vanessa Buatois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody 2024 ·Frontiers in Immunology ·Anja Seckinger, Vanessa Buatois, Valéry Moine, Bruno Daubeuf, Françoise Richard, Laurence Chatel, (unknown), (unknown), (unknown), Krzysztof Masternak, (unknown), (unknown), (unknown), (unknown), Yves Poitevin, Dirk Hose	2
2	CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model 2022 ·Experimental Hematology and Oncology ·Xavier Chauchet, Laura Cons, Laurence Chatel, Bruno Daubeuf, Gérard Didelot, Valéry Moine, Didier Chollet, Pauline Malinge, Guillemette Pontini, Krzysztof Masternak, Walter Ferlin, Vanessa Buatois, Limin Shang	20
3	752P Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer 2022 ·Annals of Oncology ·(unknown), (unknown), Valéry Moine, (unknown), Bruno Daubeuf, Vanessa Buatois, Franck Gueneau, Ulla Ravn, Krzysztof Masternak, Yves Poitevin, Giovanni Magistrelli, Pauline Malinge, (unknown), Nicolas Fischer, (unknown), Walter Ferlin, (unknown)	1
4	Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies 2021 ·European Journal of Immunology ·(unknown), Vanessa Buatois, Laura Cons, Laurence Chatel, Guillemette Pontini, (unknown), Walter Ferlin	14
5	Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 2019 ·Haematologica ·Pietro Merli, Ignazio Caruana, Rita De Vito, Luisa Strocchio, Gerrit Weber, Francesca Del Bufalo, Vanessa Buatois, P. Montanari, Maria Giuseppina Cefalo, Angela Pitisci, Mattia Algeri, Federica Galaverna, Concetta Quintarelli, Valentina Cirillo, Daria Pagliara, Walter Ferlin, Maria Ballabio, Cristina de Min, Franco Locatelli	49
6	Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine 2017 ·Journal of Biological Chemistry ·Pauline Bonvin, Franck Gueneau, Vanessa Buatois, (unknown), (unknown), Marie C. Messmer, Urs Christen, Andrew D. Luster, Zoë Johnson, Walter Ferlin, Marie Kosco‐Vilbois, Amanda E. I. Proudfoot, Nicolas Fischer	15
7	Abstract B37: NI-1701, a bispecific antibody for selective neutralization of CD47 in B cell malignancies 2017 ·Cancer Immunology Research ·Krzysztof Masternak, Xavier Chauchet, Vanessa Buatois, (unknown), Limin Shang, Zoë Johnson, Elie Dheilly, Valéry Moine, Walter Ferlin, Marie Kosco‐Vilbois, Nicolas Fischer	4
8	Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis 2016 ·Translational research ·Vanessa Buatois, Laurence Chatel, Laura Cons, (unknown), Françoise Richard, François Guilhot, Zoë Johnson, Claudia Bracaglia, Fabrizio De Benedetti, Cristina de Min, Marie Kosco‐Vilbois, Walter Ferlin	46
9	A CD47xCD19 Bispecific Antibody That Remodels the Tumor Microenvironment for Improved Killing and Provokes a Memory Immune Response to Cancer B Cells 2016 ·Blood ·Walter Ferlin, Xavier Chauchet, Vanessa Buatois, (unknown), Limin Shang, Elie Dheilly, Krzysztof Masternak, Zoë Johnson, John F. DiPersio, Julie Ritchey, Linda Eissenberg, Marie Kosco‐Vilbois, Nicolas Fischer	1
10	Abstract B54: Antagonizing CD47-SIRP alpha interaction with a bispecific antibody: A novel cancer immunotherapy approach 2015 ·Cancer Immunology Research ·Krzysztof Masternak, Zoë Johnson, Vanessa Buatois, François Rousseau, Giovanni Magistrelli, Valéry Moine, Ulla Ravn, Franck Gueneau, Lucile Broyer, (unknown), Maureen R. Deehan, Nicolas Fischer, Walter Ferlin, Marie Kosco‐Vilbois	1
11	Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex 2015 ·Journal of Biological Chemistry ·(unknown), François Rousseau, François Guilhot, Pauline Malinge, Giovanni Magistrelli, Suzanne Herren, Simon A. Jones, Gareth W. Jones, Jürgen Scheller, Rami Lissilaa, Marie Kosco‐Vilbois, Zoë Johnson, Vanessa Buatois, Walter Ferlin	54
12	Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences 2012 ·PLoS ONE ·(unknown), Ulla Ravn, Vanessa Buatois, Franck Gueneau, Sébastien Calloud, Marie Kosco‐Vilbois, Nicolas Fischer	20
13	The Inflammatory Preatherosclerotic Remodeling Induced by Intermittent Hypoxia Is Attenuated by RANTES/CCL5 Inhibition 2011 ·American Journal of Respiratory and Critical Care Medicine ·Claire Arnaud, Pauline Béguin, Sylvie Lantuéjoul, Jean‐Louis Pépin, Christiane Guillermet, Graziano Pelli, Fabienne Burger, Vanessa Buatois, Christophe Ribuot, Jean-Philippe Baguet, François Mach, Patrick Lévy, Maurice Demattéis	107
14	NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis 2011 ·Oxford University Research Archive (ORA) (University of Oxford) ·Greg Elson, Theresa H. Page, Vanessa Buatois, Bruno Daubeuf, Laurence Chatel, Laura Cons, (unknown), (unknown), Walter Ferlin, Marie Kosco‐Vilbois, Kim S. Midwood, (unknown)	5
15	CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice 2011 ·European Heart Journal ·Fabrizio Montecucco, Vincent Braunersreuther, Sébastien Lenglet, Bénédicte M. A. Delattre, Graziano Pelli, Vanessa Buatois, François Guilhot, Katia Galan, Nicolas Vuilleumier, Walter Ferlin, Nicolas Fischer, Jean‐Paul Vallée, Marie Kosco‐Vilbois, François Mach	114
16	Toll-like Receptor 4 Signaling by Follicular Dendritic Cells Is Pivotal for Germinal Center Onset and Affinity Maturation 2010 ·Immunity ·Alexandre Garin, Michael Meyer‐Hermann, (unknown), Marc Thilo Figge, Vanessa Buatois, Matthias Gunzer, Kai‐Michael Toellner, Greg Elson, Marie Kosco‐Vilbois	84
17	Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system 2010 ·Protein Expression and Purification ·Giovanni Magistrelli, Pauline Malinge, Rami Lissilaa, (unknown), François Guilhot, Valéry Moine, Vanessa Buatois, Yves Delneste, Stephan Kellenberger, Franck Gueneau, Ulla Ravn, Marie Kosco‐Vilbois, Nicolas Fischer	12
18	Pan–CC Chemokine Neutralization Restricts Splenocyte Egress and Reduces Inflammation in a Model of Arthritis 2010 ·The Journal of Immunology ·Vanessa Buatois, (unknown), Giovanni Magistrelli, Laurence Chatel, Nicolas Fischer, Marie Kosco‐Vilbois, Walter Ferlin	21
19	Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity 2010 ·The Journal of Immunology ·Rami Lissilaa, Vanessa Buatois, Giovanni Magistrelli, Anwen S. Williams, Gareth W. Jones, Suzanne Herren, Limin Shang, Pauline Malinge, François Guilhot, Laurence Chatel, Eric Hatterer, Simon A. Jones, Marie Kosco‐Vilbois, Walter Ferlin	49
20	MHC Class II-Peptide Complexes in Dendritic Cell Lipid Microdomains Initiate the CD4 Th1 Phenotype 2003 ·The Journal of Immunology ·Vanessa Buatois, (unknown), Stéphane Bécart, Nuala Mooney, Lee Leserman, Patrick Machy	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact